Plasma ctDNA enables early detection of temozolomide resistance mutations in glioma
- Author(s)
- Jones, JJ; Jones, KL; Wong, SQ; Whittle, J; Goode, D; Nguyen, H; Iaria, J; Stylli, S; Towner, J; Pieters, T; Gaillard, F; Kaye, AH; Drummond, KJ; Morokoff, AP;
- Details
- Publication Year 2024-01,Volume 6,Issue #1,Page vdae041
- Journal Title
- Neuro-Oncology Advances
- Publication Type
- Research article
- Abstract
- BACKGROUND: Liquid biopsy based on circulating tumor DNA (ctDNA) is a novel tool in clinical oncology, however, its use has been limited in glioma to date, due to low levels of ctDNA. In this study, we aimed to demonstrate that sequencing techniques optimized for liquid biopsy in glioma patients can detect ctDNA in plasma with high sensitivity and with potential clinical utility. METHODS: We investigated 10 glioma patients with tumor tissue available from at least 2 surgical operations, who had 49 longitudinally collected plasma samples available for analysis. Plasma samples were sequenced with CAPP-seq (AVENIO) and tissue samples with TSO500. RESULTS: Glioma-derived ctDNA mutations were detected in 93.8% of plasma samples. 25% of all mutations detected were observed in plasma only. Mutations of the mismatch repair (MMR) genes MSH2 and MSH6 were the most frequent circulating gene alterations seen after temozolomide treatment and were frequently observed to appear in plasma prior to their appearance in tumor tissue at the time of surgery for recurrence. CONCLUSIONS: This pilot study suggests that plasma ctDNA in glioma is feasible and may provide sensitive and complementary information to tissue biopsy. Furthermore, plasma ctDNA detection of new MMR gene mutations not present in the initial tissue biopsy may provide an early indication of the development of chemotherapy resistance. Additional clinical validation in larger cohorts is needed.
- Publisher
- Oxford University Press
- Keywords
- biomarkers; ctDNA; glioblastoma; glioma; liquid biopsy
- Department(s)
- Laboratory Research
- Publisher's Version
- https://doi.org/10.1093/noajnl/vdae041
- Open Access at Publisher's Site
https://doi.org/10.1093/noajnl/vdae041- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-07-11 01:41:17
Last Modified: 2024-07-11 01:48:04